Christopher D. Johnson

Christopher D. Johnson serves as the Director of National Accounts at VERO Biotech since March 2025, following a role as Director of Business Development at Ob Hospitalist Group. Prior experience includes significant contributions across various leadership positions at Beyond Air®, Mallinckrodt Pharmaceuticals, Cornerstone Therapeutics, United Therapeutics, Novartis, Kos Pharmaceuticals, and Watson Pharmaceuticals. Notably, Christopher improved territory rankings, achieved consistent revenue growth, and developed strategic programs like the Duke Critical Care Preceptorship. Educational background includes a Bachelor of Business Administration in Marketing from Georgia Southern University.